indications for insulin in Type 2 diabetes mellitus
Last reviewed 01/2018
Ensure that existing treatment is taken properly.
Insulin treatment should be considered in patients with inadequately controlled blood glucose levels - which is considered as a glycated haemoglobin (HbA1c) level of 7.5% or more (or a other higher level agreed with the individual) (1)
Other indications include:
- continued weight loss (even if insidious), persistent symptoms or both.
The introduction of insulin therapy in these patients almost always results
in substantial improvement in well-being
- in non-obese patients with poor diabetic control but without symptoms,
whose weight is stable and who are conscientious with existing therapy
- obese patients without symptoms but whose weight is stable present a management
dilemma: the correct therapy is intensification of diet - however a few of
these patients will benefit from treatment with insulin. A three month trial
of therapy with insulin can be a method of determining the efficacy of insulin
in the individual patient
- often insulin therapy is required in patients with intercurrent illness.
After recovery from the illness insulin therapy is withdrawn provided adequate
control is achieved and maintained
- the development of hyperlipidaemia or early diabetic complications strengthens
the decision to tighter control by starting insulin therapy
- if pregnancy is planned, patients are generally switched to insulin therapy
Reference:
- 1. National Institute for Health and Clinical Excellence (NICE) 2009. Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes
- 2. Prescribers' Journal (2000); 40 (1):38-48.